Steven Cohen Concert Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $8.4 $0 - $11.3 Million	-1,340,300 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $4.64 Million - $6.25 Million	1,069,700 Added 395.31%	1,340,300 $7.83 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $1.16 Million - $1.95 Million	270,600 New	270,600 $1.81 Million
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $4.34 Million - $11.7 Million	-893,741 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $1.13 Million - $1.52 Million	118,741 Added 15.32%	893,741 $11.3 Million

Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $5.12 Million - $6.39 Million	590,862 Added 320.88%	775,000 $7.61 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $1.44 Million - $2.12 Million	184,138 New	184,138 $1.83 Million
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $797,590 - $1.66 Million	-57,134 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $794,733 - $874,721	57,134	57,134 $843,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.